Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial

  • Linda Sharp*
  • , Seonaidh Cotton
  • , Julian Little
  • , Nicola M. Gray
  • , Margaret Cruickshank
  • , Louise Smart
  • , Alison Jane Thornton
  • , Norman Waugh
  • , Leslie Walker
  • , The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Downloads (Pure)

Abstract

BACKGROUND: Large numbers of women who participate in cervical screening require follow-up for minor cytological abnormalities. Little is known about the psychological consequences of alternative management policies for these women. We compared, over 30-months, psychosocial outcomes of two policies: cytological surveillance (repeat cervical cytology tests in primary care) and a hospital-based colposcopy examination.

METHODS: Women attending for a routine cytology test within the UK NHS Cervical Screening Programmes were eligible to participate. 3399 women, aged 20-59 years, with low-grade abnormal cytology, were randomised to cytological surveillance (six-monthly tests; n = 1703) or initial colposcopy with biopsies and/or subsequent treatment based on colposcopic and histological findings (n = 1696). At 12, 18, 24 and 30-months post-recruitment, women completed the Hospital Anxiety and Depression Scale (HADS). A subgroup (n = 2354) completed the Impact of Event Scale (IES) six weeks after the colposcopy episode or first surveillance cytology test. Primary outcomes were percentages over the entire follow-up period of significant depression (≥ 8) and significant anxiety (≥ 11; "30-month percentages"). Secondary outcomes were point prevalences of significant depression, significant anxiety and procedure-related distress (≥ 9). Outcomes were compared between arms by calculating fully-adjusted odds ratios (ORs) for initial colposcopy versus cytological surveillance.

RESULTS: There was no significant difference in 30-month percentages of significant depression (OR = 0.99, 95% CI 0.80-1.21) or anxiety (OR = 0.97, 95% CI 0.81-1.16) between arms. At the six-week assessment, anxiety and distress, but not depression, were significantly less common in the initial colposcopy arm (anxiety: 7.9% vs 13.4%; OR = 0.55, 95% CI 0.38-0.81; distress: 30.6% vs 39.3%, OR = 0.67 95% CI 0.54-0.84). Neither anxiety nor depression differed between arms at subsequent time-points.

CONCLUSIONS: There was no difference in the longer-term psychosocial impact of management policies based on cytological surveillance or initial colposcopy. Policy-makers, clinicians, and women themselves can be reassured that neither management policy has a significantly greater psychosocial cost.

TRIAL REGISTRATION: Controlled-Trials.com ISRCTN 34841617.

Original languageEnglish
Article numbere80092
Number of pages13
JournalPloS ONE
Volume8
Issue number12
DOIs
Publication statusPublished - 30 Dec 2013

Funding

TOMBOLA was funded by the Medical Research Council (Grant Number G9700808) and the NHS in England and Scotland. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Keywords

  • 5-year follow-up
  • depression scale
  • hospital anxiety
  • event scale
  • psychological impact
  • long-term
  • colposcopy
  • women
  • borderline
  • cytology

Fingerprint

Dive into the research topics of 'Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial'. Together they form a unique fingerprint.

Cite this